Frank Czul

964 total citations
25 papers, 610 citations indexed

About

Frank Czul is a scholar working on Epidemiology, Genetics and Hepatology. According to data from OpenAlex, Frank Czul has authored 25 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 10 papers in Genetics and 9 papers in Hepatology. Recurrent topics in Frank Czul's work include Inflammatory Bowel Disease (10 papers), Microscopic Colitis (8 papers) and Liver Disease Diagnosis and Treatment (6 papers). Frank Czul is often cited by papers focused on Inflammatory Bowel Disease (10 papers), Microscopic Colitis (8 papers) and Liver Disease Diagnosis and Treatment (6 papers). Frank Czul collaborates with scholars based in United States and Uruguay. Frank Czul's co-authors include Andrés Yarur, María T. Abreu, Maria A. Quintero, Cynthia Levy, Dan J. Stein, Dilpesh Agrawal, Jamie S. Barkin, Amir Patel, Vikram Kanagala and Caroline S. Fox and has published in prestigious journals such as Gastroenterology, Journal of Hepatology and The American Journal of Gastroenterology.

In The Last Decade

Frank Czul

23 papers receiving 604 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank Czul United States 12 387 363 200 118 109 25 610
Daniel Keter Israel 10 497 1.3× 463 1.3× 224 1.1× 54 0.5× 62 0.6× 15 664
Annalisa Aratari Italy 16 541 1.4× 465 1.3× 279 1.4× 55 0.5× 56 0.5× 42 742
Edward Shelton Australia 10 271 0.7× 293 0.8× 136 0.7× 115 1.0× 59 0.5× 19 502
Abhinav Vasudevan Australia 13 271 0.7× 216 0.6× 118 0.6× 59 0.5× 47 0.4× 52 424
Marina Beltrami Italy 9 578 1.5× 496 1.4× 254 1.3× 42 0.4× 65 0.6× 17 713
Gherardo Tapete Italy 11 360 0.9× 279 0.8× 147 0.7× 149 1.3× 58 0.5× 24 588
Urpo Nieminen Finland 12 453 1.2× 423 1.2× 324 1.6× 86 0.7× 44 0.4× 20 696
Paula Ministro Portugal 15 420 1.1× 333 0.9× 224 1.1× 93 0.8× 33 0.3× 58 647
Marianne Kajbæk Vester-Andersen Denmark 15 407 1.1× 358 1.0× 193 1.0× 47 0.4× 41 0.4× 19 533
Pilar López Serrano Spain 14 317 0.8× 813 2.2× 166 0.8× 167 1.4× 606 5.6× 41 1.1k

Countries citing papers authored by Frank Czul

Since Specialization
Citations

This map shows the geographic impact of Frank Czul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Czul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Czul more than expected).

Fields of papers citing papers by Frank Czul

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Czul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Czul. The network helps show where Frank Czul may publish in the future.

Co-authorship network of co-authors of Frank Czul

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Czul. A scholar is included among the top collaborators of Frank Czul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Czul. Frank Czul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mantero, Alejandro, Judith Pignac-Kobinger, Ana M. Santander, et al.. (2022). Combining Pentoxifylline With Vedolizumab for Crohn’s Disease: Results of a Randomised, Placebo-controlled Pilot Study. Journal of Crohn s and Colitis. 16(11). 1687–1695. 1 indexed citations
3.
Mantero, Alejandro, Judith Pignac-Kobinger, Jennifer Rodriguez, et al.. (2021). Fr539 COMBINED EFFECT OF PENTOXIFYLLINE WITH VEDOLIZUMAB IN THE MANAGEMENT OF PATIENTS WITH CROHN'S DISEASE. Gastroenterology. 160(6). S–353. 1 indexed citations
4.
Yarur, Andrés, Anjali Jain, Maria A. Quintero, et al.. (2018). Inflammatory Cytokine Profile in Crohn’s Disease Nonresponders to Optimal Antitumor Necrosis Factor Therapy. Journal of Clinical Gastroenterology. 53(3). 210–215. 6 indexed citations
5.
Yarur, Andrés, Vikram Kanagala, Dan J. Stein, et al.. (2017). Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn's disease. Alimentary Pharmacology & Therapeutics. 45(7). 933–940. 210 indexed citations
6.
Czul, Frank & Kalyan Ram Bhamidimarri. (2016). Noninvasive Markers to Assess Liver Fibrosis. Journal of Clinical Gastroenterology. 50(6). 445–457. 11 indexed citations
7.
Yarur, Andrés, Maria A. Quintero, Anjali Jain, et al.. (2016). Serum Amyloid A as a Surrogate Marker for Mucosal and Histologic Inflammation in Patients with Crohnʼs Disease. Inflammatory Bowel Diseases. 23(1). 158–164. 49 indexed citations
8.
Sclair, Seth N., Olveen Carrasquillo, Frank Czul, et al.. (2016). Quality of Care Provided by Hepatologists to Patients with Cirrhosis at Three Parallel Health Systems. Digestive Diseases and Sciences. 61(10). 2857–2867. 18 indexed citations
9.
Czul, Frank, et al.. (2016). Age of Diagnosis is Associated with Disease Presentation and Therapeutic Complications in Patients with Crohnʼs Disease. Inflammatory Bowel Diseases. 22(5). 1027–1031. 17 indexed citations
10.
Barkin, Jodie A., et al.. (2016). Gastric Enterovirus Infection: A Possible Causative Etiology of Gastroparesis. Digestive Diseases and Sciences. 61(8). 2344–2350. 13 indexed citations
12.
Yarur, Andrés, Frank Czul, Daniel A. Sussman, et al.. (2015). Concentrations of 6-Thioguanine Nucleotide Correlate With Trough Levels of Infliximab in Patients With Inflammatory Bowel Disease on Combination Therapy. Clinical Gastroenterology and Hepatology. 13(6). 1118–1124.e3. 121 indexed citations
13.
Czul, Frank, Eugene R. Schiff, Cynthia Levy, et al.. (2015). P0878 : First ribavirin-free sofosbuvir and simeprevir treatment of Hepatitis C genotype 1 patients with severe renal impairment (GFR <30 ml/min or dialysis). Journal of Hepatology. 62. S670–S671. 6 indexed citations
14.
Czul, Frank & Cynthia Levy. (2015). Novel Therapies on Primary Biliary Cirrhosis. Clinics in Liver Disease. 20(1). 113–130. 4 indexed citations
15.
Yarur, Andrés, Frank Czul, & Cynthia Levy. (2014). Hepatobiliary Manifestations of Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 20(9). 1655–1667. 34 indexed citations
16.
Czul, Frank, Andrés Yarur, & Kalyan Ram Bhamidimarri. (2014). Serum Vitamin B12 Level Could Be a Novel Diagnostic Marker to Predict Cirrhosis in Patients With Chronic Liver Disease. The American Journal of Gastroenterology. 109. S185–S186. 1 indexed citations
17.
Chen, Emerson Y., Seth N. Sclair, Frank Czul, et al.. (2013). A Small Percentage of Patients With Hepatitis C Receive Triple Therapy With Boceprevir or Telaprevir. Clinical Gastroenterology and Hepatology. 11(8). 1014–1020.e2. 22 indexed citations
18.
Yarur, Andrés, Frank Czul, Amar R. Deshpande, et al.. (2013). Predictive factors for clinically actionable computed tomography findings in inflammatory bowel disease patients seen in the emergency department with acute gastrointestinal symptoms. Journal of Crohn s and Colitis. 8(6). 504–512. 26 indexed citations
19.
Czul, Frank, et al.. (2013). Primary Biliary Cirrhosis. Clinics in Liver Disease. 17(2). 229–242. 27 indexed citations
20.
Czul, Frank & Jorge Lascano. (2011). An uncommon hazard: Pulmonary talcosis as a result of recurrent aspiration of baby powder. Respiratory Medicine CME. 4(3). 109–111. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026